Interleukin-2 as therapy for HIV disease. Dinitrochlorobenzene Study Group
Goldberg, B.
New England Journal of Medicine 333(3): 192; Author Reply 193
1995
ISSN/ISBN: 0028-4793 PMID: 7791830 Document Number: 445375
Document emailed within 1 workday
Related Documents
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36Sievers, E.L.; Lange, B.J.; Sondel, P.M.; Krailo, M.D.; Gan, J.; Tjoa, T.; Liu-Mares, W.; Feig, S.A. 2000: Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia Cancer Journal from Scientific American 6(Suppl): S39-S44
Vitali, C.; Bencivelli, W.; Isenberg, D.A.; Smolen, J.S.; Snaith, M.L.; Sciuto, M.; Neri, R.; Bombardieri, S. 1992: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clinical and Experimental Rheumatology 10(5): 541-547
Chérin, P.; Gherardi, R.K. 1998: Emergence of a new entity, the macrophagic myofasciitis. GERMMAD Study Group of the French Association Against Myopathies. Study and Research Group on Acquired Dysimmunity-related Muscle Disease Revue du Rhumatisme 65(10): 541-542
Illig, L.; Paul, E.; Bödeker, R.H. 1984: Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years) Anticancer Research 4(4-5): 293-298
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Kanamaru, A.; Takemoto, Y.; Kakishita, E.; Dohy, H.; Kodera, Y.; Moriyama, Y.; Shibata, A.; Kasai, M.; Katoh, S.; Saitoh, H. 1995: FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group Bone Marrow Transplantation 15(6): 885-889
Rea, T.H.; Mongan, E.S.; Lorber, A. 1980: Absence of an apparent influence of long-term parenteral gold therapy upon dinitrochlorobenzene sensitization and responsivity to intradermal antigens Journal of Rheumatology 7(3): 425-426
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Izumi, T.; Yoshida, M.; Kamaro, T.; Sato, H. 1986: Comparative clinical study of SF-SP therapy and SF-SP plus BH-AC therapy in gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(11): 3215-3220
Zhang, T.; Kazuyoshi, K.; Mahboob, H.Qureshi.; Tang, Y.; Atsushi, S. 2003: Combined therapy of interleukin-12 and interleukin-18 against Cryptococcus neoformans infection in a murine model Chinese Medical Journal 116(5): 669-672
Gollnick, S.O.; Liu, X.; Owczarczak, B.; Musser, D.A.; Henderson, B.W. 1997: Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo Cancer Research 57(18): 3904-3909
Lotze, M.T.; Hellerstedt, B.; Stolinski, L.; Tueting, T.; Wilson, C.; Kinzler, D.; Vu, H.; Rubin, J.T.; Storkus, W.; Tahara, H.; Elder, E.; Whiteside, T. 1997: The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy Cancer Journal from Scientific American 3(Suppl 1): S109-S114
Signore, A.; Pozzilli, P.; Di Mario, U.; Sensi, M.; Beales, P.; Andreani, D. 1985: Inhibition of the receptor for interleukin-2 induced by carbimazole: relevance for the therapy of autoimmune thyroid disease Clinical and Experimental Immunology 60(1): 111-116
Cojocaru, I.M.; Cojocaru, M.; Miu, G.; Sapira, V. 2011: Study of interleukin-6 production in Alzheimer's disease Romanian Journal of Internal Medicine 49(1): 55-58
Nitschke, R.; Starling, K.; Lui, V.K.; Pullen, J. 1981: Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: a Southwest Oncology Group Study Cancer Treatment Reports 65(11-12): 1105-1108
Chu, C.-J.; Lu, R.-H.; Wang, S.-S.; Chang, F.-Y.; Lin, S.-Y.; Yang, C.-Y.; Lin, H.-C.; Chang, C.-Y.; Wu, M.-Y.; Lee, S.-D. 2007: Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease Hepato-Gastroenterology 54(79): 2045-2048
Mihaela Spîrchez; Sama, G.şca; Ianc, M.; Bolba, C.; Miu, N. 2012: Relation of Interleukin-6, TNF-Alpha and Interleukin-1α with Disease Activity and Severity in Juvenile Idiopathic Arthritis Patients Clinical Laboratory 58(3-4): 253-260
Rampart, M.; Herman, A.G.; Grillet, B.; Opdenakker, G.; Van Damme, J. 1992: Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease Laboratory Investigation; a Journal of Technical Methods and Pathology 66(4): 512-518
Yan, H-bing.; Li, W-zheng.; Zhao, H-jun.; Song, L.; Zheng, B.; Zhou, P.; Liu, C. 2011: Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease Zhonghua Xin Xue Guan Bing Za Zhi 39(2): 142-146